We report the case of 47-year-old man with HIV and hepatitis C virus-associated cirrhosis who, following discontinuation of his antiretroviral therapy (ART), rapidly developed hepatic decompensation. On restarting his ART there was a noticeable improvement in his liver function, which was attributed to regaining good HIV virus control. Further data on the effects of restarting ART after ART cessation-associated hepatic decompensation are needed.
TorrianiFJRodriguez-TorresMRockstrohJK. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med2004; 351: 438–450.
2.
GaneEJStedmanCAHylandRH. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med2013; 368: 34–44.
3.
QurishiNKreuzbergCLuchtersG. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet2003; 362: 1708–1713.
4.
López-DiéguezMMontesMLPascual-ParejaJF. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS2011; 25: 899–904.
5.
Martin-CarboneroLde LedinghenVMorenoA. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. J Viral Hepat2009; 16: 790–795.
6.
de LédinghenVBarreiroPFoucherJ. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat2008; 15: 427–433. doi: 10.1111/j.1365-2893.2007.00962.x.
7.
BräuNSalvatoreMRíos-BedoyaCF. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol2006; 44: 47–55.
8.
PinedaJAAguilar-GuisadoMRiveroA. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. Clin Infect Dis2009; 49: 1274–1282.
9.
BrunoRSacchiPPuotiM. Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. J Acquir Immune Defic Syndr2007; 46: 297–303.
10.
TumaPJarrinIDel AmoJ. Survival of HIV-infected patients with compensated liver cirrhosis. AIDS2010; 24: 745–753.
11.
TedaldiEPetersLNeuhausJ. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis2008; 47: 1468–1475.
12.
MerchanteNGirón-GonzálezJAGonzález-SerranoM. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS2006; 20: 49–57.
